General Lung Cancer

General Lung Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
Cancer Type:

Articles

At ASCO 2018, Dr. Melissa Loh presented a study titled: "Chance of Cure in Advanced Cancer: What Do Older Patients Believe and How Are These Beliefs Related to Their Preferences?". This study looked at patients and their beliefs regarding a cure for cancer, specifically in older patients with advanced cancer. Patients who are certain that they could be cured pose unique challenges for physicians and shows a need for clear communication between patients and their physicians regarding the outcome of treatment and quality of life.
​​​​​​ The Global Resource for Advancing Cancer Education (GRACE) in partnership with Swedish Cancer Institute presents: Local Therapies for...
Cancer Journey:
Cancer Type:
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
Cancer Type:
Are there things that physicians and patients can do to make the decision making process easier for lung cancer patients in some way? The survey takes approximately 15 minutes or less to complete.
Cancer Journey:
Cancer Type:
Disease Learning:
Read Part 1 Smoking is the most common cause of lung cancer - 85% of lung cancer patients have smoked at some point in their lives (or, stated...
Cancer Journey:
Cancer Type:
Disease Learning:

Community Forum

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...
Cancer Journey:
Cancer Type:
Hi All - I was approached by a WhatNext Group partnered with Rare Patient Voice, with the opportunity to participate in a study specifically for Non-...
Cancer Journey:
Cancer Type:
Disease Learning:
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
Cancer Type:
Hello friends, My mom, (aged 77, Adenocarcinoma NSCLC, Stage 4, EGFR and ALK negative) was diagnosed in 2014, underwent VATS and pleurodesis,...
Cancer Journey:
Cancer Type:
My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
Cancer Type: